The first event in the sequence of reactions that leads to an allergic response is the interaction of IgE with its high-affinity receptor, FceRI, on mast cells and basophils. Our aim is to define the structural details of the IgE-FceKI interaction, to provide a rational basis for the design of agents to interfere with this process and thus with the allergic response. Such studies will also contribute to our general understanding of molecular recognition between members of the immunoglobulin superfamily. We seek to identify the sequences involved in the interaction between the two proteins and to relate them to the three-dimensional structures of the proteins. 
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IgE
Like antibodies of other classes, IgE consists of two heavy chains and two (1c or A) light chains organized into variable (V) and constant (C) immunoglobulin domains, stabilized by disulphide bonds. The class-specific &-chain contains one V domain and four C domains. termed Ce1, Ce2, Ce3 and C E~. Cleavage of human IgE with papain produces Fab and Fc fragments; the former is similar to the IgG-Fab fragment, whereas the latter has one more heavy chain domain pair (Ce2) than the prototypic IgG-Fc. The homology of the Ce3 and C E~ sequences in IgE to those of C y 2 and C y 3 respectively in IgCl is so close that the crystal structure of the IgCl-Fc serves as an excellent model for the relevant part of IgE [ 1 1.
Hamburger was first to speculate that the mast-cell-binding site on IgE might lie in the linker region between C E~ and Ce3. on the basis of sequence differences between the E-and y-chains t'ro whom correspondence should be addressed nal sequence of Ce3 becomes protected when rat IgE is bound to FceRI on rat basophilic leukaemia cells [4] .
More detailed mapping was attempted by cloning the human e-chain cDNA and expressing DNA fragments in Escherichia colt Figure 1 Other workers, using either chimeric antibodies ( Figure 1) sequence up to Gly"' and the loop connecting the two P-strands (Arg"' to Pro35') are exposed at the surface of IgE. At the time of writing we have completed the analysis of only one of the mutations, I'ro"' to glutamic acid. This is a particularly interesting mutation, however, since it was found that the corresponding residue in IgC1, LeuLii, is critical for binding to its high-affinity receptor, FcyRI [ 121.
The original observation has been confirmed and extended to neighbouring amino acids [13] [14] [15] , and there seems to be little doubt that this lower hinge region of IgC is recognized by its Fc receptors. W e found that the substitution of Pro"' by glutamic acid in the IgE Fc increased the rate of dissociation from the recombinant human FceRI, expressed on a Chinese-hamster-ovary cell line [ 161 fivefold. By contrast, the rate of association of the Glu"' mutant with FceRI and the affinity for the low-affinity IgE receptor, FceRII, were unchanged (Table l), suggesting that the mutation has not grossly changed the conformation of Ce3. This shows that the proline either is in the active site or is involved in determining the structure of this region of Ce3. Further mutants are now being studied.
FcERI
FcrRI consists of four polypeptide chains, apy2.
The IgE-binding site is in the extracellular part of the a-chain, and the /?-and y-chains are implicated in signal transduction. Examination of the extracelMar region of the a-chain of FceRI reveals that it consists of two domains, which we refer to as a( 1) and a (2) , that belong to the immunoglobulin superfamily. These, however, cannot be classified as either V-like or C-like, but belong rather to an intermediate type known as C2 [ 171. Until recently, no three-dimensional structure of a C2-type domain had been determined, but the crystal structures of the extracellular domains of CD4 [18-201 and of CD2 [21] , and in particular the second domain of CD2 [CD2(2)], which has been classified as C2-type, have proved to be extremely helpful for (1) as the better template. Once the strand regions of both domains had been assigned, the loop regions were modelled. Where homologous loops of equal length that fitted the geometrical constraints of the flanking strands could be found within immunoglobulin-like domains, these were selected [for example, CD4 (2) was used for four loops]; for the remainder, the search was extended to the whole Hrookhaven Protein Data Bank. Stereochemistry at the splice regions between strands and loops was regularized, and the side chains of some residues were manually adjusted, before dynamics simulation (for loop regions) and energy minimization routines were applied to the model. The modelling was performed using HOMOLOGY and DISCOVER (Hiosym Technologies Inc.); a detailed description will be published elsewhere (R. J. Sutton, A. J. Reavil and H. J. Gould, unpublished work). Co-ordinates were taken from the Brookhaven Protein Data Rank, except those for CD2, which were kindly provided by Drs. David Stuart and Yvonne Jones, Laboratory of Molecular Biophysics, Oxford.
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The two-domain structure of CD2 affords a model for the relative positioning of a( 1) and a (2) , since the lengths of the linkers between the two domains are the same in both. However, there is no sequence similarity between the linker regions of the a-chain and of CD2; furthermore, there is a slight difference (7") in the relative orientation of the two domains of CD2 in the two independent copies of the CD2 molecule in the crystal structure, and this variability is expected to be even greater in solution [21] . Modelling of the a(l)/a(2) interaction on CD2 must at best yield only a first approximation to the structure. Nevertheless, when Volume 
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Immunoglobulin Su perfam il y Interactions this is done, none of the loop regions conflict with each other, and a number of hydrophobic residues are found to be buried in the proposed interface.
It is known that the principal determinants of the IgE-binding site lie in a(2) [23, 24] . A schematic representation of this domain is shown in Figure 2 , which also indicates the locations of the three putative N-linked glycosylation sites in human a(2). These three asparagine residues [as well as the four potential glycosylation sites in a(l)] all lie in exposed surface regions of the model. It is known that glycosylation does not interfere with binding IgE, but the location of the IgE-binding site within a(2) has yet to be determined. The interaction is blocked, however, by an antibody to an a(2) peptide [25] that corresponds to the H-strand and HC loop in the model (coloured black in Figure 2 ). It may be that the antibody recognizes the loop region, since there is a potential glycosylation site adjacent to the B-strand segment. Also, it has been suggested that a stretch of seven residues conserved in the human and rat a-chain sequences, but not in the homologous preceptors, forms a part of the site
[26]; these residues correspond to strand C (crosshatched in Figure 2 ). Mapping studies of the binding site for IgC within the homologous second extracellular domain of FcyRII [24, 271 also indicate that a segment corresponding to strands F and G and to the intervening loop, constitutes a major part of the site (shaded grey in Figure 2 ). Finally, a polymorphism in FcyRII has been shown to affect binding IgC [27] ; the corresponding position in a(2) lies at the end of the C' strand (black circle in Figure 2 ). With the further supposition that the binding sites on IgC and IgE occupy equivalent positions on their homologous receptors, all the available evidence points to the four-strand face (C'-C-F-G) as the determinant of the IgE-FceRIa interaction. This face is free of potential glycosylation sites that might interfere with binding IgE. Site-specific mutagenesis experiments are in progress in our laboratory to test this proposition, and to identify key residues in the interaction.
A model of the complex with IgE may now be envisaged. Resonance-energy transfer experiments on IgE suggest that it is bent [28] , and we have argued previously that the IgE-binding site is on the convex surface [29] . In outline, the argument rests on the observation that only one &-chain is involved in binding [5] , and that the stoichiometry of the -that on the convex surface. Figure 3 illustrates the suggested mode of interaction, and incorporates the distance between IgE and the cell membrane inferred from resonance-energy transfer [28] . This model also allows us to rationalize the influence of a(1) on the binding of IgE to a site in the a (2) domain [23] ; we regard these models as a useful . .
sites on opposite sides of the molecule would generframework for the design of future experiments.
